Cytek Biosciences Inc (CTKB) — Free Cash Flow Generation Index
Cytek Biosciences Inc (CTKB) has a Free Cash Flow Generation Index of -13.60x as of June 2025. Free cash flow of $-1.47 Million represents -14% of operating cash flow ($108.00K). See working capital to net assets of Cytek Biosciences Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cytek Biosciences Inc Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for Cytek Biosciences Inc across 4 annual periods. Explore Cytek Biosciences Inc (CTKB) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Cytek Biosciences Inc (2020–2024)
Year-by-year Free Cash Flow Generation Index for Cytek Biosciences Inc. For the full company profile including market capitalisation, see CTKB company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | $21.85 Million | $25.38 Million | $3.52 Million | ▲ +901.7% |
| 2023 | 0.09x | $454.00K | $5.28 Million | $4.83 Million | ▲ +49.6% |
| 2021 | 0.06x | $266.00K | $4.63 Million | $4.36 Million | ▼ -93.6% |
| 2020 | 0.90x | $13.61 Million | $15.16 Million | $1.55 Million | — |